CTI Clinical Trial Solutions and Consulting Services is partnering with Medidata to facilitate remote monitoring and reviews for clinical trials across the globe.
According to a press release, CTI will utilize Medidata’s Remote Source Review solution.
“Medidata is committed to developing and deploying the technology necessary to maintain the momentum of discovery,” Medidata Co-Founder and Co-CEO Glen de Vries said in a statement. “We’re pleased to be partnering with CTI on these important, promising trials for patients with rare and infectious diseases, and cancer. It’s more important than ever that we think and plan our way around the obstacles COVID-19 has put in the path of medical progress.”
To read the full press release, click here.